Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Role of Rifaximin on Thrombocytopenia in Patients With Hepatitis C-Related Liver Cirrhosis

NCT07791940 is registered in ClinicalTrials.gov with Fayoum University Hospital as lead sponsor.

NCT NCT07791940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07791940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Role of Rifaximin on Thrombocytopenia in Patients With Hepatitis C-Related Liver Cirrhosis
Lead sponsor
Fayoum University Hospital
Phase
Phase 4
Overall status
Completed
Start date
October 19, 2015
Completion date
December 30, 2017
Enrollment
200 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

thrombocytopenia related to chronic liver disease